COLORADO SPRINGS, Colo. —With no differences in failure rates, patient-reported outcomes, pain or return to play, both allograft and autograft are viable options for patients undergoing medial patellofemoral ligament reconstruction.
“There is limited literature comparing autograft and allograft in medial patellofemoral ligament (MPFL) reconstruction,” Jeffrey Henstenburg, MD, said in his presentation at the American Orthopaedic Society for Sports Medicine Annual Meeting. “Cost is time spent for harvest but theoretically, [autograft] provides superior strength and a